Approval · Notice of Compliance 10292 · 2009
SYNALAR SOLUTION 0.01%: Notice of Compliance 10292
Issued June 24, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10292
- Date
- June 24, 2009
- Company
- Valeo Pharma Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Topical corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNALAR SOLUTION 0.01% | 02162504 | Cancelled Post Market |
| SYNALAR OINTMENT 0.025% | 02162512 | Dormant |
Medicinal ingredients
- FLUOCINOLONE ACETONIDE 0.01 PER
- FLUOCINOLONE ACETONIDE 0.025 PER